ASOCIACIÓN ENTRE LA OBESIDAD Y EL CÁNCER DE MAMA PREMENOPÁUSICO

Autores/as

  • Maria Stefania Nóbrega Batista
  • Lara Moreira Mendes Carneiro
  • Polyana Magna Dias Balbino

DOI:

https://doi.org/10.47820/recima21.v3i10.2081

Palabras clave:

Obesidad , Cáncer de mama, Premenopausal.

Resumen

Teniendo en cuenta el aumento en el número de casos de cáncer, especialmente el cáncer de mama, es evidente la necesidad de comprender los factores de riesgo de la enfermedad. Como la obesidad y el cáncer afectan a millones de personas y tienen consecuencias importantes, es necesario identificar la relación entre estos dos eventos. El objetivo de este estudio es definir si existe una asociación entre la obesidad y el cáncer de mama premenopáusico. Se realizó una revisión integradora de la literatura con los descriptores en Ciencias de la Salud "Obesidad" Y "Cáncer de mama" Y "Premenopáusica" en las siguientes bibliotecas virtuales: MEDLINE, PUBMED, LILACS y SCIELO. Las líneas de evidencia que apoyan la asociación de la obesidad con el cáncer de mama incluyen vías relacionadas con la inflamación, la resistencia a la insulina y la síntesis hormonal. En la premenopáusica, los estudios indican una relación inversa entre estos dos factores, es decir, las pacientes obesas tendrían un menor riesgo de cáncer; con la excepción de las mujeres asiáticas, que tienen un mayor riesgo. Sin embargo, la obesidad, cuando está presente, confiere un peor pronóstico, mayor riesgo de recurrencia y mortalidad por cáncer de mama en mujeres premenopáusicas, especialmente porque se relaciona con subtipos tumorales más agresivos.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Maria Stefania Nóbrega Batista

Universidade Federal de Campina Grande

Lara Moreira Mendes Carneiro

Universidade Federal do Piauí

Polyana Magna Dias Balbino

Enfermeira especialista de Saúde da Mulher. Universidade Federal de Campina Grande

Citas

ALMENDROS, T.; GILELES-HILLEL, A.; KHALYFA, A. Adipose tissue macrophage polarization by intermittent hypoxia in a mouse model of OSA: effect of tumor microenvironment. Cancer Letters, v. 361(2), p. 233–239, 2015.

AMADOU, A.; FERRARI, P.; MUWONGE, R.; MOSKAL, A.; BIESSY, C.; ROMIE

U, I.; HAINAU, P. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obesity Reviews, 2013.

ANDERSON, L.G. NEUHOUSE, M.L. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prevention Research, v. 5(4), p. 515–521, 2012.

BLIGIA, N.; PEANO, E.; SGANDURRA, P.; MOGGIO, G.; PECCHIO, S.; MAGGIOROTTO, F.; SISMONDI, P. Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. Gynecological Endocrinology, v. 29:3, p. 263-267, 2013.

BRAUN, S.; BITTON-WORMS, K.; LEROITH, D. The link between the metabolic syndrome and cancer. International journal of biological sciences, v. 7, n. 7, p. 1003, 2011.

BRAY, G.A.; POPKIN, B.M. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health be damned! Pour on the sugar. Diabetes Care, 2014.

BULUN, S.E.; PRICE, T.M.; AITKEN, J.; MAHENDROO, M.S.; SIMPSON, E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. The Journal of Clinical Endocrinology & Metabolism, v. 77, p. 1622-1628, 1993.

DIVISION OF CANCER PREVENTION AND CONTROL CENTERS FOR DESEASE CONTROL PREVENTION. What Are the Risk Factors for Breast Cancer? Disponível em: www.cdc.gov/cancer/breast/basic_info/risk_factors.htm 2021. Acessado em 12 de Agosto de 2022.

DOWSETT, M.; FOLKERD, E. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Research Treatmen, v. 149, p. 1–4, 2015.

GUILHERME, A.; VIRBASIUS, J.V.; PURI, V.; CZECH, M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology, v. 9, p. 367-377, 2008.

INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. Atlas da mortalidade. Rio de Janeiro: INCA, 2021. Base de dados. Disponível em: https://www.inca.gov.br/app/mortalidade. Acesso em: 12 de Agosto de 2022.

INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. Estimativa 2020: incidência do Câncer no Brasil. Rio de Janeiro: INCA, 2019a. Disponível em: https://www.inca.gov.br/estimativa/taxas-ajustadas/neoplasia-maligna-da-mama-feminina-e-colo-do-utero. Acesso em: 10 de Agosto de 2022.

INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. INCA estima que haverá cerca de 600 mil casos novos de câncer em 2018. Rio de Janeiro: INCA, 2018. Disponível em: www.inca.gov.br/imprensa/inca-estima-que-havera-cerca-de-600-mil-casos-novos-de-cancer-em-2018. Acesso em: 10 de Agosto de 2022.

LAHMANN, P. Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC). International Journal Of Cancer, v. 111, n. 5, p. 762-771, 2004.

LAUDISIO, D.; MUSCOGIURI, G.; BARREA, L.; SAVASTANO, S.; COLAO, A. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2018.

LOUIE, S.M.; ROBERTS, L.S.; NOMURA, D.K. Mechanisms linking obesity and cancer. Biochim Biophys Acta, 2013.

MENDES, K.D.S.; SILVEIRA, R.C.C.P; GALVÃO, C.M. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enfermagem, v. 17, p.758-764, 2008.

NINDREA, R.D.; ARYANDONO, T.; LAZUARDI, L.; DWIPRAHASTO, I. Association of Overweight and Obesity with Breast Cancer During Premenopausal Period in Asia: A Meta-Analysis. International Journal of Preventive Medicine, 10: 192, 2019.

OLOPADE, O.I.; GRUSHKO, T.A.; NANDA, R.; HUO, R. Advances in breast cancer: pathways to personalized medicine. Clinical Cancer Research, v.14 (24), p. 7988–7999, 2008.

ORGANIZAÇÃO MUNDIAL DE SAÚDE. Câncer de mama agora forma mais comum de câncer: OMS tomando medidas. Disponível em: http://who.int/pt/news/item/03-02-2021-breast-cancer-now-most-commom-form-of-cancer-who-taking-action.

RENEHAN, A.G.; TYSON, E.M.; HELLER, R.F.; ZWAHLEN, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008.

TAI, E.S.; LAU, T.N.; HO, S.C.; FOK, A;C.; TAN, C.E. Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. International Journal of Obesity and Related Metabolic Disorders, v. 24, p.751–757, 2000.

TORRES-DE LA ROCHE, L.A.; STELJES, I.; JANNI, W.; FRIEDL, T.W.P.; WILDE, R.L. The Association between Obesity and Premenopausal Breast Cancer According to Intrinsic Subtypes - a Systematic Review. GebFra Science, v. 80, p. 601-610, 2020.

TURKOZ, F.P.; SOLAK, M.; PETEKKAYA, I.; KESKIN, O.; KERTMEN, N.; SARICI, F.; ARIK, Z.; BABACAN, T.; OZISIK, Y.; ALTUNDA. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. JBUON, v. 18(2), p. 335-341, 2013.

UDICKI, M.; ADAMOVIC, D.; SRDIC-GALIC, T.P.; RADOVANIC, Z. Anthropometric and Somatotype Characteristics of Women with Breast Cancer. International Journal of Morphology, v. 38, n. 2, 2020.

URBUTE, A.; FREDERIKSEN, K.; KJAER, S.K. Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women. Annals of Epidemiology, v. 60, p. 61-67, 2022.

Publicado

26/10/2022

Cómo citar

Batista, M. S. N. ., Carneiro, L. M. M. ., & Balbino , P. M. D. . (2022). ASOCIACIÓN ENTRE LA OBESIDAD Y EL CÁNCER DE MAMA PREMENOPÁUSICO. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 3(10), e3102081. https://doi.org/10.47820/recima21.v3i10.2081